Analysts expect Hamilton Thorne Ltd (CVE:HTL) to report $0.00 EPS on May, 23. It closed at $0.88 lastly. It is down 6.00% since April 11, 2017 and is uptrending. It has underperformed by 5.59% the S&P500.
Auburn National Bancorporation, Inc
Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The company has market cap of $68.75 million. The Firm offers Clinical lasers, Research lasers and Clinical Sperm Analysis Products. It has a 108.91 P/E ratio. The Company’s Clinical lasers include LYKOS laser and ZILOS-tk laser for applications, such as laser-assisted hatching and embryo biopsy for pre-implantation genetic diagnosis .
Since January 1, 0001, it had 13 insider purchases, and 3 insider sales for $68,727 activity.
It closed at $34.51 lastly. It is down 25.35% since October 4, 2016 and is uptrending. It has outperformed by 13.77% the S&P500.
Banc Funds Co Llc holds 0.15% of its portfolio in Auburn National Bancorporation Inc for 115,811 shares. Lincoln National Corp owns 16,055 shares or 0.03% of their US portfolio. Moreover, Stevens First Principles Investment Advisors has 0.02% invested in the company for 1,000 shares. The Georgia-based Suntrust Banks Inc has invested 0.01% in the stock. Alliancebernstein L.P., a New York-based fund reported 11,294 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.